Similarly, another study showed that anti-PD1 treatment can inhibit the expression of PDL1 induced by c-Met inhibitors, and the combination of c-Met inhibitor and anti-PD1 can better control the tumor progression (Glodde et al., 2017). Here, CD274 is linked to neoplasm.